Cited by 41Down syndrome and intellectual disability researchNeuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental Disorders

Altered Distribution of Hippocampal Interneurons in the Murine down Syndrome Model Ts65Dn.

Hernández-González, Samuel, Ballestín, Raúl, López-Hidalgo, Rosa, Gilabert-Juan, Javier, Blasco-Ibáñez, José Miguel, Crespo, Carlos, Nácher, Juan, Varea, Emilio·2015·Neurochemical Research

Abstract

Down Syndrome, with an incidence of one in 800 live births, is the most common genetic alteration producing intellectual disability. We have used the Ts65Dn model, that mimics some of the alterations observed in Down Syndrome. This genetic alteration induces an imbalance between excitation and inhibition that has been suggested as responsible for the cognitive impairment present in this syndrome. The hippocampus has a crucial role in memory processing and is an important area to analyze this imbalance. In this report we have analysed, in the hippocampus of Ts65Dn mice, the expression of synaptic markers: synaptophysin, vesicular glutamate transporter-1 and isoform 67 of the glutamic acid decarboxylase; and of different subtypes of inhibitory neurons (Calbindin D-28k, parvalbumin, calretinin, NPY, CCK, VIP and somatostatin). We have observed alterations in the inhibitory neuropil in the hippocampus of Ts65Dn mice. There was an excess of inhibitory puncta and a reduction of the excitatory ones. In agreement with this observation, we have observed an increase in the number of inhibitory neurons in CA1 and CA3, mainly interneurons expressing calbindin, calretinin, NPY and VIP, whereas parvalbumin cell numbers were not affected. These alterations in the number of interneurons, but especially the alterations in the proportion of the different types, may influence the normal function of inhibitory circuits and underlie the cognitive deficits observed in DS.

Integrity signals

Registry

Crossref · 10.1007/s11064-014-1479-8

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Ts65Dn hippocampus, there is a significant increase in calretinin positive neurons and no change in parvalbumin positive neurons.

    “A third study also assessed the interneuron content of the hippocampus and again identified a significant increase in calretinin positive neurons with no change in parvalbumin positive neurons (Hernandez-Gonzalez et al., 2015).”

    From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Hernandez-Gonzalez et al., 2015

  • Striking conservation was found in the ratio of ExN:InN (2.17:1) and the ratio of MGE:CGE InNs (1.4:1) in both control and Ts21 samples.

    “Whereas Ts21 mouse models have identified alterations in the balance of ExN and InN (43-45), we found striking conservation in the ratio of ExN:InN (2.17:1) and the ratio of MGE:CGE InNs (1.4:1) in both control and Ts21 samples (Fig. 4B).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hernández-González, S., Ballestín, R., López-Hidalgo, R., Gilabert-Juan, J., Blasco-Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E.
Affiliations
Universitat de València (ES)
Corresponding author
Varea, Emilio
Venue
Neurochemical Research
Published
2014-11-16
Volume
40
Issue
1
Pages
151-164
ISSN
  • 0364-3190 (ISSN-L)
  • 1573-6903
OpenAlex
W2036979318
Cited by
41
References
8
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2022: 7 · 2021: 2 · 2020: 5 · 2019: 7 · 2018: 1 · 2017: 5 · 2016: 5 · 2015: 1
FWCI
3.63
Type
journal article
Language
en
Open access
closed
Locations
  • Neurochemical Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
Down syndrome, Ts65Dn mouse model, hippocampal interneurons, inhibitory neurons, excitatory-inhibitory imbalance, synaptic markers, synaptophysin, VGLUT1, glutamic acid decarboxylase, parvalbumin, calbindin, calretinin, neuropeptide Y, cholecystokinin, VIP, somatostatin, CA1, CA3, intellectual disability, cognitive impairment
MeSH terms
Animals, Calcium-Binding Proteins, Down Syndrome, Hippocampus, Interneurons, Mice, Inbred C57BL, Nerve Tissue Proteins, Neuropeptides, Synapses, Neuropil, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review